TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Life Science Byrån LSB AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
131
|
135
|
146 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
39
|
49
|
59 |
| EBITDA |
38
|
49
|
59 |
| Total assets |
130
|
128
|
121 |
| Current assets |
103
|
111
|
115 |
| Current liabilities |
18
|
19
|
18 |
| Equity capital |
106
|
102
|
96 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
81.5%
|
79.7%
|
79.3% |
| Turnover per employee |
131
|
135
|
146 |
| Profit as a percentage of turnover |
29.8%
|
36.3%
|
40.4% |
| Return on assets (ROA) |
30.0%
|
38.3%
|
48.8% |
| Current ratio |
572.2%
|
584.2%
|
638.9% |
| Return on equity (ROE) |
36.8%
|
48.0%
|
61.5% |
| Change turnover |
-5
|
1
|
11 |
| Change turnover % |
-4%
|
1%
|
8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.